Display options
Cite
Endlich K, Massfelder T, Helwig JJ, et al. Vascular effects of parathyroid hormone and parathyroid hormone-related protein in the split hydronephrotic rat kidney. J Physiol. 1995;483:481-90doi: 10.1113/jphysiol.1995.sp020599.
Endlich, K., Massfelder, T., Helwig, J. J., & Steinhausen, M. (1995). Vascular effects of parathyroid hormone and parathyroid hormone-related protein in the split hydronephrotic rat kidney. The Journal of physiology, 483481-90. https://doi.org/10.1113/jphysiol.1995.sp020599
Endlich, K, et al. "Vascular effects of parathyroid hormone and parathyroid hormone-related protein in the split hydronephrotic rat kidney." The Journal of physiology vol. 483 (1995): 481-90. doi: https://doi.org/10.1113/jphysiol.1995.sp020599
Endlich K, Massfelder T, Helwig JJ, Steinhausen M. Vascular effects of parathyroid hormone and parathyroid hormone-related protein in the split hydronephrotic rat kidney. J Physiol. 1995 Mar 01;483:481-90. doi: 10.1113/jphysiol.1995.sp020599. PMID: 7650615; PMCID: PMC1157858.
Copy Download .nbib Format: NLM
Share it on
Full text links
Wiley Free PMC Article

J Physiol. 1995 Mar 01;483:481-90. doi: 10.1113/jphysiol.1995.sp020599.

Vascular effects of parathyroid hormone and parathyroid hormone-related protein in the split hydronephrotic rat kidney.

The Journal of physiology

K Endlich, T Massfelder, J J Helwig, M Steinhausen

Affiliations

  1. I Physiologisches Institut, Universität Heidelberg, Germany.

PMID: 7650615 PMCID: PMC1157858 DOI: 10.1113/jphysiol.1995.sp020599
Free PMC Article

Abstract

1. The effects of locally applied parathyroid hormone-related protein (PTHRP), a putative autocrine/paracrine hormone, on vascular diameters and glomerular blood flow (GBF) in the split hydronephrotic rat kidney were studied. As PTHRP interacts with parathyroid hormone (PTH) receptors in all tissues tested so far, the effects of PTHRP were compared with those of PTH. 2. Preglomerular vessels dilated in a concentration- and time-dependent manner that was almost identical for PTH and PTHRP. A significant preglomerular vasodilation (5-17%) occurred at a threshold concentration of 10(-10) mol l-1 PTH or PTHRP, which raised GBF by 20 +/- 2 and 31 +/- 4%, respectively (means +/- S.E.M., n = 6). PTH or PTHRP (10(-7) mol l-1) increased preglomerular diameters (11-36%) and GBF (60 +/- 10 and 70 +/- 8%, respectively) to near maximum. The most prominent dilatation was located at the interlobular artery and at the proximal afferent arteriole. 3. Efferent arterioles were not affected by either PTH or PTHRP. 4. Estimated concentrations of half-maximal response (EC50) for preglomerular vasodilatation and GBF increase were in the nanomolar to subnanomolar range. 5. After inhibition of angiotensin I-converting enzyme by 2 x 10(-6) mol kg-1 quinapril I.V. (n = 6), 10(-8) mol l-1 PTHRP dilated preglomerular vessels and efferent arterioles (9 +/- 1% proximal and 6 +/- 1% distal). 6. We conclude that the renal vasculature of the hydronephrotic kidney is highly sensitive to vasodilatation by PTH and PTHRP, which, in addition, may constrict efferent arterioles by stimulating renin release.(ABSTRACT TRUNCATED AT 250 WORDS)

References

  1. Endocrinology. 1990 Feb;126(2):721-7 - PubMed
  2. Naunyn Schmiedebergs Arch Pharmacol. 1989 Aug;340(2):246-51 - PubMed
  3. Eur J Pharmacol. 1989 Dec 19;174(2-3):139-51 - PubMed
  4. Proc Natl Acad Sci U S A. 1990 Sep;87(18):6969-73 - PubMed
  5. Kidney Int. 1990 Nov;38(5):769-84 - PubMed
  6. J Pharmacol Exp Ther. 1991 Jan;256(1):110-8 - PubMed
  7. Endocrinology. 1991 Apr;128(4):1927-37 - PubMed
  8. Pharmacology. 1991;42(2):91-6 - PubMed
  9. Endocrinology. 1991 Sep;129(3):1233-42 - PubMed
  10. J Clin Invest. 1991 Dec;88(6):1841-7 - PubMed
  11. J Appl Physiol. 1967 Feb;22(2):333-7 - PubMed
  12. Pflugers Arch. 1976 Jan 30;361(2):191-5 - PubMed
  13. Am J Physiol. 1978 May;234(5):F393-401 - PubMed
  14. Pharmacology. 1980;21(3):213-22 - PubMed
  15. Am J Cardiol. 1982 Apr 21;49(6):1430-3 - PubMed
  16. Am J Physiol. 1983 May;244(5):F526-34 - PubMed
  17. Kidney Int. 1983 Jun;23(6):794-806 - PubMed
  18. Endocrinology. 1986 Jul;119(1):349-56 - PubMed
  19. Recent Prog Horm Res. 1986;42:705-50 - PubMed
  20. Virchows Arch A Pathol Anat Histopathol. 1986;410(1):31-42 - PubMed
  21. Eur J Pharmacol. 1987 Aug 21;140(3):247-57 - PubMed
  22. Am J Physiol. 1987 Oct;253(4 Pt 2):R634-9 - PubMed
  23. J Clin Invest. 1987 Dec;80(6):1803-7 - PubMed
  24. Biochem Biophys Res Commun. 1987 Nov 30;149(1):227-32 - PubMed
  25. J Biol Chem. 1993 Jan 25;268(3):1987-94 - PubMed
  26. Clin Sci (Lond). 1993 Jan;84(1):11-9 - PubMed
  27. Am J Physiol. 1993 Aug;265(2 Pt 2):F285-92 - PubMed
  28. Kidney Int. 1993 Oct;44(4):764-73 - PubMed
  29. J Physiol. 1993 Sep;469:571-82 - PubMed
  30. Am J Physiol. 1994 Feb;266(2 Pt 2):H583-9 - PubMed
  31. Clin Sci (Lond). 1994 Mar;86(3):245-9 - PubMed
  32. Br J Pharmacol. 1994 Jan;111(1):238-44 - PubMed
  33. J Physiol. 1991 Dec;444:303-15 - PubMed
  34. Proc Natl Acad Sci U S A. 1989 Apr;86(7):2408-12 - PubMed
  35. Kidney Int. 1989 May;35(5):1151-60 - PubMed
  36. Endocr Rev. 1989 Nov;10(4):420-36 - PubMed

Substances

MeSH terms

Publication Types

LinkOut - more resources